LivaNova PLC (NASDAQ:LIVN) – Investment analysts at Jefferies Group decreased their Q1 2018 earnings per share estimates for shares of LivaNova in a report released on Monday. Jefferies Group analyst R. Denhoy now forecasts that the company will post earnings of $0.62 per share for the quarter, down from their previous estimate of $0.76. Jefferies Group currently has a “Buy” rating and a $91.00 price target on the stock.
A number of other equities research analysts have also recently weighed in on LIVN. BidaskClub upgraded LivaNova from a “hold” rating to a “buy” rating in a research note on Friday, January 26th. Zacks Investment Research cut LivaNova from a “hold” rating to a “strong sell” rating in a research note on Thursday, January 25th. ValuEngine upgraded LivaNova from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Needham & Company LLC boosted their price objective on LivaNova to $93.00 and gave the company a “buy” rating in a research note on Tuesday, November 21st. Finally, Canaccord Genuity reiterated a “hold” rating and issued a $76.00 price objective on shares of LivaNova in a research note on Tuesday, December 5th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $79.71.
Several institutional investors have recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. grew its holdings in LivaNova by 9.8% during the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock worth $105,000 after acquiring an additional 153 shares during the period. Cerebellum GP LLC acquired a new position in LivaNova during the fourth quarter worth $128,000. QS Investors LLC grew its holdings in LivaNova by 27,255.6% during the fourth quarter. QS Investors LLC now owns 2,462 shares of the company’s stock worth $197,000 after acquiring an additional 2,453 shares during the period. Pillar Pacific Capital Management LLC acquired a new position in LivaNova during the fourth quarter worth $208,000. Finally, Shelton Capital Management acquired a new position in LivaNova during the third quarter worth $209,000. Institutional investors and hedge funds own 87.06% of the company’s stock.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $80.80, for a total transaction of $80,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Hugh M. Morrison sold 1,830 shares of the company’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $88.00, for a total value of $161,040.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,830 shares of company stock valued at $407,310. 0.28% of the stock is owned by company insiders.
WARNING: “LivaNova PLC to Post Q1 2018 Earnings of $0.62 Per Share, Jefferies Group Forecasts (LIVN)” was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3225150/livanova-plc-to-post-q1-2018-earnings-of-0-62-per-share-jefferies-group-forecasts-livn.html.
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.